KANTARO

EUIPO EUIPO 2021 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark KANTARO was filed as Word mark on 02/01/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/31/2021. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 018386923
Application date February 1, 2021
Publication date April 23, 2021
Entry date July 31, 2021
Expiration date February 1, 2031

Trademark owner

1460 Broadway
10036 New York
US

Trademark representatives

Prinsenkade 9D 4811 VB Breda NL

goods and services

1 Diagnostic agents, preparations, substances and diagnostic test kits used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for research purposes
5 Medical preparations; Diagnostic agents, preparations and substances for medical or veterinary purposes; Medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens and tissue; Assays, reagents, media, solutions, buffers and preparations for medical, clinical and diagnostic use; Diagnostic agents for carrying out serologic tests for medical purposes; Diagnostic reagents for serologic tests of infections for medical purposes; Diagnostic agents, preparations, substances and diagnostic test kits used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for medical and clinical purposes; Kits and components for use in diagnostic testing; Test kits consisting of medical diagnostic reagents, assays, solutions and buffers for testing in the field of the prevention and treatment of infections, viruses, disorders and diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of blood, bodily fluids, biological and cellular samples and specimens and tissue for use in infection, virus and disease detection, namely, infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Antibody diagnostic test for use in disease detection; Medical test kits for coronavirus, SARS-CoV-2 and COVID-19 diagnosis and monitoring; Diagnostic preparations for medical purposes for detecting the presence of infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Preparations and substances for the diagnosis, prevention and treatment of SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders
10 Medical apparatus and instruments; Medical testing and analysis equipment and apparatus; Blood testing apparatus; Medical apparatus for collecting, processing and testing blood, bodily fluids, biological and cellular samples and specimens and tissue; Medical diagnostic instruments for the analysis of blood, body fluids, biological and cellular samples and specimens and tissue; Apparatus for analysis of biological materials for medical purposes; Medical apparatus and instruments for laboratory analysis, clinical diagnosis and treatment of infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Tools and devices for medical diagnostics; Medical apparatus, instruments and devices for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Kits for testing for the presence of antibodies in blood, biological fluids, bodily fluids, biological and cellular samples and specimens and tissue for medical purposes; Medical diagnostic apparatus and devices for detecting SARS-CoV-2 and COVID-19; Diagnostic apparatus for detecting infection; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Bags, pouches and containers for the collection and preservation and transport of blood, biofluids, bodily fluids, biological and cellular samples and specimens and tissue obtained from humans and animals
42 Medical, pharmaceutical, scientific and clinical research and analysis; Medical and scientific research in the fields of viral and infectious diseases; Design and development of medical diagnostic test kits; Research, analysis, design, development and consultancy services relating to apparatus, instruments, devices and equipment for medical diagnostics and testing, medical diagnostic tests, medical devices, pharmaceutical preparations and treatments, vaccines and medicines; Providing medical testing services and information in the field of medical and viral and infectious diseases research; Development of scientific research and technology for purposes of disease testing, diagnosis, testing, monitoring, prevention, treatment, rehabilitation and health maintenance; Conducting clinical trials of medical and pharmaceutical products; Research and development of pharmaceuticals for the treatment of infections, viruses, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Providing a website in relation to information about medical devices, diagnostics, research, analysis, monitoring and treatment of infections, viruses and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Research regarding development of vaccines and medicines; Providing information, news, and commentary in the fields of medical research
44 Medical information, consultancy and advisory services; Medical and healthcare information, consultancy and advisory services relating to infections, viruses, SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Providing consulting services to medical and healthcare professionals, researchers and institutions in the fields of healthcare and diagnostic medical testing; Providing consulting services to medical and healthcare professionals, researchers and institutions in the field of virus and disease infection control; Consulting and advisory services in the fields of medical diagnostic testing, monitoring and reporting; Consulting services regarding the use of medical tests relating to the diagnosis and treatment of diseases and disorders; Providing a website in relation to information about medical testing and analysis services for diagnostic or treatment purposes in the field of infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Medical diagnosis, evaluation and analysis regarding viral and infectious diseases; Health care information, namely, information about viral and disease management programs; Providing information, news, and commentary in the fields of health, health care and medicine

ID: 11018386923